Covid vac­cine mak­ers Pfiz­er, J&J notch high brand marks amid over­all still-strong phar­ma in­dus­try rep: Har­ris Poll

Can the phar­ma in­dus­try hold on­to its pan­dem­ic-mint­ed pos­i­tive rep­u­ta­tion? So far so good, ac­cord­ing to the Har­ris Poll’s lat­est da­ta. The in­dus­try seems to have sta­bi­lized pos­i­tive opin­ions in the US, now lev­el­ing off in the mid-50 per­cent ranges, da­ta from the Har­ris Poll’s most re­cent De­cem­ber sur­vey re­veal.

Mean­while, the glob­al pic­ture is even sun­nier. The phar­ma in­dus­try notched a 59% over­all pos­i­tive in­dus­try sen­ti­ment, ahead of fi­nan­cial ser­vices (51%) and in­sur­ance (47%), and not that far be­hind typ­i­cal fa­vorites like con­sumer pack­aged goods (64%) and re­tail (66%).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER